恩福图马布维多丁的风险分析:基于FAERS数据库的现实世界方法
Fuchun Zheng1,2, Yuanzhuo Du1,2, Yuyang Yuan1,2
1Department of Urology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, 330000, China.
Heliyon
|September 23, 2024
概括
这项研究分析了恩福图马布维多丁 (EV) 的安全数据. 发现了罕见的不良事件,如状角质炎和小肠穿孔,需要进一步的临床监测.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 恩福图马布维多丁 (EV) 是一种针对晚期膀癌的向治疗.
- 现实世界的数据分析对于理解药物安全性概况至关重要.
- 联邦不良事件报告系统 (FAERS) 为药物监测提供了宝贵的来源.
研究的目的:
- 评估Enfortumab vedotin (EV) 在晚期膀癌患者的安全性.
- 通过FAERS数据库的现实数据识别潜在的安全信号.
- 分析与EV治疗相关的药物不良事件 (ADEs) 的风险.
主要方法:
- 对FAERS从2020年第一季度到2024年第一季度的数据进行了回顾性药监分析.
- 识别和分类与EV相关的不良药物事件 (ADEs).
- 使用包括比例报告比率 (ROR) 和贝叶斯方法在内的统计方法来检测安全信号.
主要成果:
- 从7,449,181个FAERS报告中,共发现了1617个与电动汽车相关的AEE.
- 关键系统器官类 (SOCs) 包括皮肤/皮下组织,代谢和营养障碍.
- 对罕见的ADEs观察到显著的不成比例:状角质炎 (ROR 26.89),小肠穿孔 (ROR 24.51),色素障碍 (ROR 18.16) 和胆炎 (ROR 17.48).
结论:
- 大多数发现与现有的电动汽车安全数据一致.
- 新的安全信号,包括状角质炎和小肠穿孔,需要进一步调查.
- 对EV相关的ADEs进行临床监测至关重要,需要进一步的研究来验证这些发现.
相关概念视频
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:12Relative Risk
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...